Shu Takayama earned his BS and MS in Agricultural Chemistry at the University of Tokyo. He earned a Ph.D. in Chemistry at The Scripps Research Institute in La Jolla, California studying bio-organic synthesis with Dr. Chi‐Huey Wong. He then worked as a postdoc with Dr. George Whitesides at Harvard University where he focused on applying microfluidics to studying cell and molecular biology.

Robert E. Guldberg is the DeArmond Executive Director of the Phil and Penny Knight Campus for Accelerating Scientific Impact and Vice President of the University of Oregon. Guldberg’s research is focused on musculoskeletal mechanobiology, regenerative medicine, and orthopaedic medical devices. Over his 25+ year academic career, Dr. Guldberg has produced over 280 peer-reviewed publications, served as an advisor and board member for numerous biotechnology companies, and co-founded six start-ups. He was previously executive director of the Parker H.

Dr. Nie received her B.S. degree in Biology from Peking University in China in 2002. In 2007, she received her Ph.D. in Cell Biology from the University of Alabama at Birmingham, where she worked on elucidating signaling pathways in vertebrate gastrulation movements. Thereafter, she conducted postdoctoral research in the laboratory of Marianne Bronner at California Institute of Technology. She joined Georgia Tech in Fall 2014.

Dr. Chang is the director of the Comparative Neuromechanics Laboratory. His research program focuses on trying to understand how animals move through and interact with their environment.

The research focus of Boris Prilutsky's laboratory is Neural Control and Biomechanics of Movement. They study how the nervous system controls hundreds of muscles and kinematic degrees of freedom of the body to produce purposeful motor behaviors and how the neural control of motor behaviors is affected by neural and musculoskeletal injuries.

Ingeborg Schmidt-Krey is an associate professor in the School of Biological Sciences at Georgia Tech. Her research interests lie in the structure and function of eukaryotic membrane proteins, two-dimensional crystallization, electron crystallography, single particle analysis, and electron cryo-microscopy (cryo-EM).

T. Richard Nichols received the B.S. degree in biology from Brown University, Providence, RI, USA, in 1969, and the Ph.D. degree in physiology from Harvard University, Cambridge, MA, USA, in 1974. He is currently a Professor in the School of Biological Sciences at the Georgia Institute of Technology.,He is currently a Professor in the School of Biological Sciences at the Georgia Institute of Technology, Atlanta, GA, USA.

Frank Rosenzweig is a Professor in School of Biological Sciences. He holds Bachelors degrees in Comparative Literature and Zoology from University of Tennessee-Knoxville, and a PhD in Biology at University of Pennsylvania. He carried out postdoctoral studies at the University of Michigan. He was a professor at University of Idaho, University of Florida, and University of Montana before joining the Georgia Tech faculty in 2016. He served as the Director of the NASA Astrobiology Institute funded center “Reliving the Past” from 2015 to 2019.

Dr. Yunker joined Georgia Tech’s School of Physics in 2014 after finishing his biophysics postdoc at Harvard University & New England Biolabs in 2014. Before that, he earned his Ph.D. in Physics from the University of Pennsylvania in 2012 after earning a B.S. in Physics from Texas A&M University in 2005. He has won the Burstein Prize and the Denenstein Award both from UPenn along with the Eric R. Immel Memorial award for Excellence in Teaching at GT. 

Peter’s interests are biophysics, soft matter, and golden retrievers.

Raquel Lieberman is the Sepcic-Pfeil Professor of Chemistry & Biochemistry at Georgia Tech. Her research program focuses on biophysical and structural characterization of proteins and the impact of disease-associated mutations on function or dysfunction (e.g. aggregation). Rooted in basic research, the long-term goal of her research program is to convert mechanistic discoveries into disease-modifying therapies.